A report from Premier discusses ER visit reductions that could result from better management of six common chronic conditions.
Read More
Colorado publishes a report outlining hospital cost-shifting in the state.
Read More
A brief from the Kaiser Family Foundation demonstrates how Medicare's share of drug spending has grown since the introduction of Part D and expansion of Part B medication use.
Read More
A survey by the American Medical Association finds that doctors still enjoy doing prior authorization and find it very beneficial for patient care, not.
Read More
Another specialty pharmacy company weighs in with a 2018 trend report on that category of medications.
Read More
A new study discusses trends in private equity firms buying physician practices.
Read More
A research letter in JAMA Internal Medicine discusses physicians perspectives on FDA expedited drug approval pathways.
Read More
A research letter in JAMA Internal Medicine describes consumer reactions to drug pricing disclosure.
Read More
A report from PriceWaterhouse Cooper evaluates the year that was in health care M & A.
Read More
A report from IQVIA covers expected spending and trends in global drug use over the next few years.
Read More
Rising drug prices are contributing to hospitals' increased costs of delivering care.
Read More
More bad news for the hospital readmission reduction program, as a new study in Health Affairs concludes that it had far less effect than previously estimated.
Read More
The annual ECRI Institute list of health safety hazards is out.
Read More
A McKinsey post addresses issues around patient adherence to treatment regimens.
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.